Disclosures for "Re-weighting MDS-UPDRS Part II Items for Optimal Sensitivity to Parkinson’s Disease Progression Using Parkinson’s Progression Markers Initiative Natural History Data"
-
Samuel Dickson has received personal compensation for serving as an employee of Pentara Corporation.
-
Ms. Rogula has nothing to disclose.
-
Dr. Dubow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Avadel Pharmaceuticals.
-
Dr. Kozauer has received personal compensation for serving as an employee of Biohaven Pharmaceuticals.
-
Lauren Powell has nothing to disclose.
-
Dr. Potashman has received personal compensation for serving as an employee of Biohaven Pharmaceuticals.
-
Dr. Crimin has received personal compensation for serving as an employee of Biohaven. Dr. Crimin has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Commonweath Advisors. Dr. Crimin has stock in AbbVie. Dr. Crimin has stock in BioHaven.
-
Dr. O'Keefe has received personal compensation for serving as an employee of Pentara. Dr. O'Keefe has received research support from NIH. An immediate family member of Dr. O'Keefe has received research support from NSF, IES & Vanderbilt Frist Center for Autism and Innovation.
-
Ms. Korol has received personal compensation in the range of $50,000-$99,999 for serving as a Lead, MHSU with Interior Health Authority.
-
Ms. Crabtree has nothing to disclose.
-
Miss Nagase has nothing to disclose.
-
Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Hendrix has received personal compensation for serving as an employee of Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pentara Corporation. The institution of Dr. Hendrix has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pentara Corporation. Dr. Hendrix has stock in Pentara.
-
Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has received stock or an ownership interest from biohaven pharmaceuticals.